These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

968 related articles for article (PubMed ID: 33161049)

  • 21. Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease.
    Grotemeyer A; Fischer JF; Koprich JB; Brotchie JM; Blum R; Volkmann J; Ip CW
    J Neuroinflammation; 2023 Mar; 20(1):79. PubMed ID: 36945016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice.
    Ou Z; Zhou Y; Wang L; Xue L; Zheng J; Chen L; Tong Q
    Mol Neurobiol; 2021 Apr; 58(4):1303-1311. PubMed ID: 33169332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia.
    Panicker N; Sarkar S; Harischandra DS; Neal M; Kam TI; Jin H; Saminathan H; Langley M; Charli A; Samidurai M; Rokad D; Ghaisas S; Pletnikova O; Dawson VL; Dawson TM; Anantharam V; Kanthasamy AG; Kanthasamy A
    J Exp Med; 2019 Jun; 216(6):1411-1430. PubMed ID: 31036561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA KCNQ1OT1 promotes NLRP3 inflammasome activation in Parkinson's disease by regulating pri-miR-186/mature miR-186/NLRP3 axis.
    Li MM; Shi MJ; Feng CC; Yu ZY; Bai XF; Lu-Lu
    Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167454. PubMed ID: 39122224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammasome Activation in Parkinson's Disease.
    Jewell S; Herath AM; Gordon R
    J Parkinsons Dis; 2022; 12(s1):S113-S128. PubMed ID: 35848038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
    Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
    J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.
    Trudler D; Nazor KL; Eisele YS; Grabauskas T; Dolatabadi N; Parker J; Sultan A; Zhong Z; Goodwin MS; Levites Y; Golde TE; Kelly JW; Sierks MR; Schork NJ; Karin M; Ambasudhan R; Lipton SA
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33833060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
    He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
    Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
    Codolo G; Plotegher N; Pozzobon T; Brucale M; Tessari I; Bubacco L; de Bernard M
    PLoS One; 2013; 8(1):e55375. PubMed ID: 23383169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study.
    Chatterjee K; Roy A; Banerjee R; Choudhury S; Mondal B; Halder S; Basu P; Shubham S; Dey S; Kumar H
    J Neuroimmunol; 2020 Jan; 338():577089. PubMed ID: 31704453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echinacoside exerts neuroprotection via suppressing microglial α-synuclein/TLR2/NF-κB/NLRP3 axis in parkinsonian models.
    Yang XP; Huang JH; Ye FL; Yv QY; Chen S; Li WW; Zhu M
    Phytomedicine; 2024 Jan; 123():155230. PubMed ID: 38000105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.
    Albornoz EA; Amarilla AA; Modhiran N; Parker S; Li XX; Wijesundara DK; Aguado J; Zamora AP; McMillan CLD; Liang B; Peng NYG; Sng JDJ; Saima FT; Fung JN; Lee JD; Paramitha D; Parry R; Avumegah MS; Isaacs A; Lo MW; Miranda-Chacon Z; Bradshaw D; Salinas-Rebolledo C; Rajapakse NW; Wolvetang EJ; Munro TP; Rojas-Fernandez A; Young PR; Stacey KJ; Khromykh AA; Chappell KJ; Watterson D; Woodruff TM
    Mol Psychiatry; 2023 Jul; 28(7):2878-2893. PubMed ID: 36316366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
    Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
    Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
    Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson's disease.
    Amo-Aparicio J; Daly J; Højen JF; Dinarello CA
    J Neuroinflammation; 2023 Jun; 20(1):147. PubMed ID: 37349821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
    Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
    Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.